ArticleCureus2026
Probable Association Between Hidradenitis Suppurativa and Inflammatory Bowel Disease: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by recurrent painful nodules, abscesses, and sinus tracts primarily affecting intertriginous areas, causing significant quality of life impairment. Follicular occlusion, microbial infection, aberrant immune responses, and genetic and environmental factors are all recognized as playing a significant role in its complex pathogenesis. On the other hand, inflammatory bowel disease (IBD) is a relapsing and remitting disorder characterized by chronic inflammation at various sites in the gastrointestinal tract. The pathogenesis of IBD is a multifaceted interplay between genetic susceptibility, dysregulated immune responses, environmental triggers, and gut microbiota alterations, or dysbiosis. Herein, we present a case of a 64-year-old man with longstanding HS, chronic colostomy, and multiple comorbidities who presented with acute bright red blood per rectum. Our extensive workup revealed multiple perianal open fistulous tracts with scarring, large external hemorrhoids, active chronic proctitis with focal crypt abscess formation and erosion, and diverticulitis with negative infectious workup. His HS remained active throughout the hospitalization. Given the combination of chronic skin lesions, active proctitis on histology, and elevated inflammatory markers, these findings raised concern for underlying IBD, although definitive diagnosis required further outpatient evaluation. This report explores the diagnostic challenges at the crossroads of HS and potential IBD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.